Ketamine in the Treatment of Major Depressive Disorder

Brent Luu; Elizabeth Rice; Philippe Goldin

doi:10.1016/j.nurpra.2019.07.016

Ketamine in the Treatment of Major Depressive Disorder

Brent Luu, Elizabeth Rice, Philippe Goldin

Betty Irene Moore School of Nursing

Research output: Contribution to journal › Article

Abstract

Major depressive disorder (MDD) is a prevalent and highly debilitating psychiatric condition that affects many young adults worldwide. This brief review summarizes the current available data about the use of ketamine as a treatment for MDD. We describe pharmacological mechanisms, dose considerations, drug interactions, side effects, and the relevancy of ketamine in the treatment of MDD.

Original language	English (US)
Pages (from-to)	228-231
Number of pages	4
Journal	Journal for Nurse Practitioners
Volume	16
Issue number	3
DOIs	https://doi.org/10.1016/j.nurpra.2019.07.016
State	Published - Mar 2020

Fingerprint

Keywords

depression
ketamine
major depressive disorder (MDD)
mechanism of ketamine
psychiatric conditions
treatment of MDD

ASJC Scopus subject areas

Advanced and Specialized Nursing

Cite this

Luu, B., Rice, E., & Goldin, P. (2020). Ketamine in the Treatment of Major Depressive Disorder. Journal for Nurse Practitioners, 16(3), 228-231. https://doi.org/10.1016/j.nurpra.2019.07.016

@article{4e1fc531a32342489b517782d0931ba1,

title = "Ketamine in the Treatment of Major Depressive Disorder",

abstract = "Major depressive disorder (MDD) is a prevalent and highly debilitating psychiatric condition that affects many young adults worldwide. This brief review summarizes the current available data about the use of ketamine as a treatment for MDD. We describe pharmacological mechanisms, dose considerations, drug interactions, side effects, and the relevancy of ketamine in the treatment of MDD.",

keywords = "depression, ketamine, major depressive disorder (MDD), mechanism of ketamine, psychiatric conditions, treatment of MDD",

author = "Brent Luu and Elizabeth Rice and Philippe Goldin",

year = "2020",

month = mar

doi = "10.1016/j.nurpra.2019.07.016",

language = "English (US)",

volume = "16",

pages = "228--231",

journal = "Journal for Nurse Practitioners",

issn = "1555-4155",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Ketamine in the Treatment of Major Depressive Disorder

AU - Luu, Brent

AU - Rice, Elizabeth

AU - Goldin, Philippe

PY - 2020/3

Y1 - 2020/3

N2 - Major depressive disorder (MDD) is a prevalent and highly debilitating psychiatric condition that affects many young adults worldwide. This brief review summarizes the current available data about the use of ketamine as a treatment for MDD. We describe pharmacological mechanisms, dose considerations, drug interactions, side effects, and the relevancy of ketamine in the treatment of MDD.

AB - Major depressive disorder (MDD) is a prevalent and highly debilitating psychiatric condition that affects many young adults worldwide. This brief review summarizes the current available data about the use of ketamine as a treatment for MDD. We describe pharmacological mechanisms, dose considerations, drug interactions, side effects, and the relevancy of ketamine in the treatment of MDD.

KW - depression

KW - ketamine

KW - major depressive disorder (MDD)

KW - mechanism of ketamine

KW - psychiatric conditions

KW - treatment of MDD

UR - http://www.scopus.com/inward/record.url?scp=85071721108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071721108&partnerID=8YFLogxK

U2 - 10.1016/j.nurpra.2019.07.016

DO - 10.1016/j.nurpra.2019.07.016

M3 - Article

AN - SCOPUS:85071721108

VL - 16

SP - 228

EP - 231

JO - Journal for Nurse Practitioners

JF - Journal for Nurse Practitioners

SN - 1555-4155

IS - 3

ER -

Access to Document

10.1016/j.nurpra.2019.07.016